From the Guidelines
Sevoflurane is associated with several potential side effects, including nausea, vomiting, emergence delirium, dose-dependent cardiovascular depression, respiratory depression, shivering, and rare but life-threatening conditions such as malignant hyperthermia and hepatotoxicity, as reported in various studies 1.
Common Side Effects
- Nausea and vomiting, affecting approximately 20-30% of patients postoperatively
- Emergence delirium, particularly in children, characterized by confusion, agitation, and combativeness upon awakening
- Dose-dependent cardiovascular depression, resulting in hypotension and decreased cardiac output
- Respiratory depression, potentially causing decreased respiratory rate and tidal volume
- Shivering during recovery
Rare but Serious Side Effects
- Malignant hyperthermia, a life-threatening condition requiring immediate treatment with dantrolene, as noted in the European Malignant Hyperthermia Group guidelines 1
- Hepatotoxicity in susceptible individuals
- Interaction with dry CO2 absorbents to produce Compound A, a potentially nephrotoxic substance, though clinical significance remains debated
Patient-Specific Considerations
- Elderly patients and those with pre-existing cardiac or respiratory conditions are at higher risk for adverse effects
- The use of sevoflurane in patients with coronary artery disease may have cardioprotective effects, as suggested by studies comparing volatile anesthetics to propofol or midazolam 1
- The choice of anesthetic technique, including the use of sevoflurane, should be individualized based on patient factors and surgical procedure, as recommended in the ACC/AHA guidelines 1 and the ERAS society recommendations 1
From the FDA Drug Label
The following adverse events have been identified during post-approval use of sevoflurane. Due to the spontaneous nature of these reports, the actual incidence and relationship of sevoflurane to these events cannot be established with certainty. Central Nervous System • Seizures — Post-marketing reports indicate that sevoflurane use has been associated with seizures • Delirium Cardiac • Cardiac arrest • QT prolongation associated with Torsade de Pointe • Bradycardia in patients with Down syndrome Hepatic • Cases of mild, moderate and severe post-operative hepatic dysfunction or hepatitis with or without jaundice have been reported. • Hepatic necrosis • Hepatic failure Other • Malignant hyperthermia • Allergic reactions, such as rash, urticaria, pruritus, bronchospasm, and anaphylactic reactions • Reports of hypersensitivity (including contact dermatitis, rash, dyspnea, wheezing, chest discomfort, swelling face, or anaphylactic reaction) have been received, particularly in association with long-term occupational exposure to inhaled anesthetic agents, including sevoflurane Laboratory Findings • Transient elevations in glucose, liver function tests, and white blood cell count may occur as with use of other anesthetic agents.
The side effects of sevoflurane include:
- Central Nervous System: seizures, delirium
- Cardiac: cardiac arrest, QT prolongation associated with Torsade de Pointe, bradycardia in patients with Down syndrome
- Hepatic: post-operative hepatic dysfunction or hepatitis, hepatic necrosis, hepatic failure
- Other: malignant hyperthermia, allergic reactions, hypersensitivity reactions
- Laboratory Findings: transient elevations in glucose, liver function tests, and white blood cell count 2
From the Research
Side Effects of Sevoflurane
- Postoperative nausea and vomiting (PONV) are common side effects of sevoflurane, with a frequency of 9.3-10.8% 3, 4
- Sevoflurane may cause respiratory depression, with a decrease in tidal volume and an increase in PaCO2 5
- Compared to desflurane, sevoflurane may have a lower incidence of late postoperative vomiting and nausea 4
- Sevoflurane may cause cough, but the incidence is lower compared to isoflurane 6
- There is no significant difference in the risk of postoperative respiratory complications between sevoflurane and desflurane 7
Comparison with Other Anesthetics
- Sevoflurane has a similar effect on PONV compared to isoflurane and desflurane 3, 4
- Sevoflurane may have a lower incidence of cough compared to isoflurane 6
- Desflurane may have a shorter time to extubation and emergence compared to sevoflurane 4
Respiratory Effects
- Sevoflurane can cause respiratory depression, with a decrease in tidal volume and an increase in PaCO2 5
- The respiratory effects of sevoflurane are similar to those of halothane, with a decrease in minute volume and an increase in PaCO2 5
- There is no significant difference in the risk of postoperative respiratory complications between sevoflurane and desflurane 7